Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance

By afschroeder • April 30, 2026

Auger WR, Krasuski RA, Mahmud E, Leary PJ, Steinberg ZL, Sandhu GS, Todoran T, Toma C, Darki A, Sethi S, Stefanescu Schmidt AC, Cuttica MJ, Schimmel DR, Frantz RR, Haddadin I, Witkin A, Channick RN, Rosenfield K, Bashir R. Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance. JACC Cardiovasc Interv. 2026 Apr 27;19(8):923-942. doi: 10.1016/j.jcin.2026.02.033. PMID: 42055655.

Tags: balloon pulmonary angioplasty, chronic thromboembolic pulmonary hypertension, inoperable chronic thromboembolic pulmonary disease, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial

Socinski MA, Stahel R, Lee DH, Cappuzzo F, Nishio M, Lovly CM, Ozyilkan O, Li Q, Johnson M, Garon EB, Kilickap S, Ferreira da Silva[...]

Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase in Aeromonas spp

von Bredow B, Trejo M, Ward KW, Trieu KP, Santellan CA, Garner OB, Yang S, Chandrasekaran S. Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]